Efficacy of acarbose and metformin in treatment of type 2 diabetes
Bian Yuhu
Abstract
Bian Yuhu
Abstract
Objective To observe the effect acarbose and metformin in treatment of type 2 diabetes. Methods Sixty-four cases of type 2 diabetes patients were treated strictly controlled diet,exercise,on the basis of each group to metformin0.5 g,orally,3 times / d,observation group were treated with acarbose 50 mg,3 times / d,lunch and dinner orally,if blood glucose control was not satisfactory,gradually increased dose to 100 mg/times,for 12 weeks.The efficacy of the two groups were compared. Results The fasting blood glucose were observed before the treatment group and the control group of patients and 2 h postprandial blood glucose compared with no significant difference(P 0.05), lower than before treatment and after treatment,fasting blood glucose and meal after 2 h plasma glucose was(8.3±1.6) mmol/L,(10.2±1.5) mmol/L,respectively,significantly lower than the control group(P0.05). After 12 weeks of treatment,the total curative rate was 93.8%(30/32) in the observation group, the total efficacy rate of the control group was 71.9%(23/32),the difference was significant group between the two groups(χ2=6.387,P0.05). Conclusion Acarbose and metformin in treatment of type 2 diabetes can significantly improve the efficacy,control blood sugar levels,safety,worthy of promotion and application.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effect acarbose and metformin in treatment of type 2 diabetes. Methods Sixty-four cases of type 2 diabetes patients were treated strictly controlled diet,exercise,on the basis of each group to metformin0.5 g,orally,3 times / d,observation group were treated with acarbose 50 mg,3 times / d,lunch and dinner orally,if blood glucose control was not satisfactory,gradually increased dose to 100 mg/times,for 12 weeks.The efficacy of the two groups were compared. Results The fasting blood glucose were observed before the treatment group and the control group of patients and 2 h postprandial blood glucose compared with no significant difference(P 0.05), lower than before treatment and after treatment,fasting blood glucose and meal after 2 h plasma glucose was(8.3±1.6) mmol/L,(10.2±1.5) mmol/L,respectively,significantly lower than the control group(P0.05). After 12 weeks of treatment,the total curative rate was 93.8%(30/32) in the observation group, the total efficacy rate of the control group was 71.9%(23/32),the difference was significant group between the two groups(χ2=6.387,P0.05). Conclusion Acarbose and metformin in treatment of type 2 diabetes can significantly improve the efficacy,control blood sugar levels,safety,worthy of promotion and application.
Key concepts: Acarbose, Medicine, Postprandial, Metformin, Type 2 diabetes, Internal medicine, Blood sugar, Diabetes mellitus